Abstract
Conjunctival lymphoma is a malignant growth of lymphoid cells on the ocular surface. Clinically, it can present either as a salmon patch or as a follicular form. The etiology of this type of cancer remains unknown, although new research has demonstrated a possible link to infectious agents including Chlamydia psittaci and hepatitis C. When the lymphoma is localized, the current standard of care is external beam radiation, although new therapeutic options include intralesional injections of interferon or rituximab. If systemic, treatment options now include doxycycline, rituximab (Rituxan), and Y-90 ibritumomab tiuxetan (Zevalin). This article explores the new research and treatment options for conjunctival lymphoma.
| Original language | English |
|---|---|
| Pages (from-to) | 63-67 |
| Number of pages | 5 |
| Journal | Techniques in Ophthalmology |
| Volume | 9 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 1 2011 |
Fingerprint
ASJC Scopus subject areas
- Ophthalmology
Cite this
Update on conjunctival lymphoma. / Telukuntla, Kartik; Karp, Carol.
In: Techniques in Ophthalmology, Vol. 9, No. 3, 01.09.2011, p. 63-67.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Update on conjunctival lymphoma
AU - Telukuntla, Kartik
AU - Karp, Carol
PY - 2011/9/1
Y1 - 2011/9/1
N2 - Conjunctival lymphoma is a malignant growth of lymphoid cells on the ocular surface. Clinically, it can present either as a salmon patch or as a follicular form. The etiology of this type of cancer remains unknown, although new research has demonstrated a possible link to infectious agents including Chlamydia psittaci and hepatitis C. When the lymphoma is localized, the current standard of care is external beam radiation, although new therapeutic options include intralesional injections of interferon or rituximab. If systemic, treatment options now include doxycycline, rituximab (Rituxan), and Y-90 ibritumomab tiuxetan (Zevalin). This article explores the new research and treatment options for conjunctival lymphoma.
AB - Conjunctival lymphoma is a malignant growth of lymphoid cells on the ocular surface. Clinically, it can present either as a salmon patch or as a follicular form. The etiology of this type of cancer remains unknown, although new research has demonstrated a possible link to infectious agents including Chlamydia psittaci and hepatitis C. When the lymphoma is localized, the current standard of care is external beam radiation, although new therapeutic options include intralesional injections of interferon or rituximab. If systemic, treatment options now include doxycycline, rituximab (Rituxan), and Y-90 ibritumomab tiuxetan (Zevalin). This article explores the new research and treatment options for conjunctival lymphoma.
UR - http://www.scopus.com/inward/record.url?scp=80053044018&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80053044018&partnerID=8YFLogxK
U2 - 10.1097/ITO.0b013e31822fe5ed
DO - 10.1097/ITO.0b013e31822fe5ed
M3 - Article
AN - SCOPUS:80053044018
VL - 9
SP - 63
EP - 67
JO - Techniques in Ophthalmology
JF - Techniques in Ophthalmology
SN - 1542-1929
IS - 3
ER -